Identification, partial purification, and characterization of a novel phospholipid-dependent and fatty acid-activated protein kinase from human platelets

J Biol Chem. 1994 Apr 1;269(13):9729-35.

Abstract

A novel lipid-dependent protein kinase in human platelets was partially purified and characterized. This enzyme was calcium-independent and was selective for phosphatidic acid as a cofactor/activator with initial activation observed at approximately 2 mol % and peak activity achieved at 4 mol % phosphatidic acid. In the presence of phosphatidylserine, enzyme activation was observed with concentrations of phosphatidic acid as low as 0.5 mol % with peak activity at 2 mol %. Other anionic phospholipids also activated the enzyme but to a lesser extent and with less potency. Enzyme activity was independent of diacylglycerol or phorbol esters and the enzyme did not bind [3H]phorbol dibutyrate. In a soluble protein kinase assay, the enzyme was activated by cis-unsaturated fatty acids with maximum activation occurring at 5-10 microM sodium oleate. Western blot analysis showed that this enzyme did not cross-react immunologically with antibodies raised against the currently identified isoenzymes of protein kinase C. A number of additional biochemical criteria distinguished this enzyme from known isoenzymes of protein kinase C. These biochemical and immunologic data define a novel lipid-dependent protein kinase in human platelets. The role of this enzyme in signal transduction as a phosphatidic acid-activated enzyme and as a possible target for cis-unsaturated fatty acids is discussed.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • Blood Platelets / enzymology*
  • Blotting, Western
  • Calcium / pharmacology
  • Chromatography
  • Chromatography, Affinity
  • Chromatography, Ion Exchange
  • Diglycerides / pharmacology
  • Durapatite
  • Enzyme Activation
  • Humans
  • Isoquinolines / pharmacology
  • Kinetics
  • Oleic Acid
  • Oleic Acids / pharmacology*
  • Phorbol 12,13-Dibutyrate / metabolism
  • Phospholipids / pharmacology*
  • Piperazines / pharmacology
  • Protein Kinase Inhibitors
  • Protein Kinases / blood*
  • Protein Kinases / isolation & purification*
  • Sphingosine / pharmacology
  • Substrate Specificity

Substances

  • Diglycerides
  • Isoquinolines
  • Oleic Acids
  • Phospholipids
  • Piperazines
  • Protein Kinase Inhibitors
  • Oleic Acid
  • Phorbol 12,13-Dibutyrate
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • Durapatite
  • Protein Kinases
  • Sphingosine
  • Calcium